Spatial heterogeneity analysis of p16Ink4A expression in neuroendocrine and non-neuroendocrine tumors, revealed that p16Ink4A immunoreactivity is homogeneous across different areas of lung tumors, with the same recurring pattern of expression. The gene discussed is CDKN2A; the disease is neuroendocrine neoplasm.